Oxford Lithium Trial (OxLith) of the early affective, cognitive, neural and biochemical effects of lithium carbonate in bipolar disorder: study protocol for a randomised controlled trial
Despite lithium's being the most effective drug for bipolar disorder and in clinical use for decades, we still know very little about its early effects relevant to its mode of action.The Oxford Lithium Trial is a double-blind, randomised, placebo-controlled study of 6-week lithium treatment in...
Main Authors: | Saunders, K, Cipriani, A, Rendell, J, Attenburrow, M, Nelissen, N, Bilderbeck, A, Vasudevan, S, Churchill, G, Goodwin, G, Nobre, A, Harmer, C, Harrison, P, Geddes, J |
---|---|
Format: | Journal article |
Language: | English |
Published: |
BioMed Central
2016
|
Similar Items
-
Oxford Lithium Trial (OxLith) of the early affective, cognitive, neural and biochemical effects of lithium carbonate in bipolar disorder: study protocol for a randomized controlled trial
by: Saunders, K, et al.
Published: (2016) -
Older patients are eligible for trial of lithium and valproate.
by: Rendell, J, et al.
Published: (2003) -
New trial should clarify lithium use in bipolar disorder.
by: Geddes, J, et al.
Published: (2002) -
Lith6
by: Malcolm A. Lyons, et al.
Published: (2003-09-01) -
The Oxford study of calcium channel antagonism, cognition, mood instability and sleep (OxCaMS): Study protocol for a randomised controlled, experimental medicine study
by: Atkinson, L, et al.
Published: (2019)